✦ LIBER ✦

Novel therapies in hepatitis B and C

✍ Scribed by Bart Takkenberg; Joep de Bruijne; Christine Weegink; Peter Jansen; Hendrik Reesink

Book ID: 107538359
Publisher: Springer
Year: 2008
Tongue: English
Weight: 530 KB
Volume: 10
Category: Article
ISSN: 1522-8037
DOI: 10.1007/s11894-008-0013-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pediatric issues in new therapies for he

Pediatric issues in new therapies for hepatitis B and C

✍ Kathleen B. Schwarz 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 383 KB

Development of novel antiviral therapies

Development of novel antiviral therapies for hepatitis C virus

✍ Kai Lin 📂 Article 📅 2010 🏛 SP Wuhan Institute of Virology, CAS 🌐 English ⚖ 526 KB

New therapies for hepatitis C

✍ Apurva A. Modi; Jay H. Hoofnagle 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

See Articles on Pages 631 and 640. N o challenge in clinical hepatology is as great today as the management of patients with chronic hepatitis C who have failed to respond to an adequate course of antiviral therapy. At present, the optimal regimen is a combination of peginterferon and ribavirin. 1 W

Hepatitis B Therapy in Pregnancy

✍ Natalie H. Bzowej 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 324 KB

All decisions about initiating, continuing, or stopping therapy of the hepatitis B virus (HBV) during pregnancy must include an analysis of the risks and benefits for mother and fetus. The trimester of the pregnancy and the stage of the mother's liver disease are important factors. Treatment in the

Old and emerging therapies in chronic he

Old and emerging therapies in chronic hepatitis C: an update

✍ M. Deutsch; S.J. Hadziyannis 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Challenges and successes in developing n

Challenges and successes in developing new therapies for hepatitis C

✍ De Francesco, Raffaele; Migliaccio, Giovanni 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 406 KB